【Bong-Ray Biotech Co., Ltd.】Q1 2026 EPS of TWD 0.97
Key facts
- 【Bong-Ray Biotech Co., Ltd.】Q1 2026 EPS of TWD 0.97
- Bong-Ray Biotech Co., Ltd. announced its Q1 2026 financial results, achieving an EPS of TWD 0.97, operating revenue of TWD 0.84 billion, and net profit after tax of TWD 0.24 billion. The company, operating in the biotechnology and medical industry, demonstrated solid performance.
- Source: PR Times
- Date: March 1, 2026
Direct answer
Bong-Ray Biotech Co., Ltd. announced its Q1 2026 financial results, achieving an EPS of TWD 0.97, operating revenue of TWD 0.84 billion, and net profit after tax of TWD 0.24 billion. The company, operating in the biotechnology and medical industry, demonstrated solid performance.
- Citation
- 【Bong-Ray Biotech Co., Ltd.】Q1 2026 EPS of TWD 0.97 (March 1, 2026), PR Times
- Source
- PR Times
- Date
- March 1, 2026
Bong-Ray Biotech Co., Ltd. announced its Q1 2026 financial results, achieving an EPS of TWD 0.97, operating revenue of TWD 0.84 billion, and net profit after tax of TWD 0.24 billion. The company, operating in the biotechnology and medical industry, demonstrated solid performance.
📋 Article Processing Timeline
- 📰 Published: March 1, 2026 at 09:00
- 🔍 Collected: May 14, 2026 at 08:00 (1775h 0m after Published)
- 🤖 AI Analyzed: May 14, 2026 at 08:06 (5 min after Collected)
Company Name: Bong-Ray Biotech Co., Ltd.
Industry: Biotechnology and Medical Industry
Fiscal Year/Quarter: 2026 Q1
Basic Earnings Per Share: TWD 0.97
Operating Revenue: TWD 0.84 Billion
Net Income After Tax: TWD 0.24 Billion
FAQ
What are the key facts in this article?
Bong-Ray Biotech Co., Ltd. announced its Q1 2026 financial results, achieving an EPS of TWD 0.97, operating revenue of TWD 0.84 billion, and net profit after tax of TWD 0.24 billion. The company, operating in the biotechnology and medical industry, demonstrated solid performance.
What is the direct answer?
Bong-Ray Biotech Co., Ltd. announced its Q1 2026 financial results, achieving an EPS of TWD 0.97, operating revenue of TWD 0.84 billion, and net profit after tax of TWD 0.24 billion. The company, operating in the biotechnology and medical industry, demonstrated solid performance.
What is the source and date?
PR Times: https://openapi.twse.com.tw/financial/twse-fin-6955-2026Q1 | March 1, 2026